Portfolio company
Strata Oncology
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides genomic profiling tests and data software to help healthcare systems and pharmaceutical firms match cancer patients with precision therapies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Foundation Medicine
This company develops genomic profiling tests to help doctors and researchers identify treatment options for cancer patients.
Astron Health
This company develops a precision oncology platform that provides molecular data analysis and personalised treatment reports for cancer patients and their clinicians.
Flatiron Health
This company develops oncology software and data platforms for cancer centres and life science organisations to improve patient care and clinical research.
GenomOncology
This company develops software platforms to analyse and interpret genomic data for molecular pathology labs, clinical oncologists and research institutions.
Veracyte
This company develops genomic tests and diagnostic tools to help clinicians and patients make informed treatment decisions for various types of cancer.
Tempus
This company provides data-driven genomic sequencing and clinical analysis tools to healthcare providers and pharmaceutical companies for personalised patient care and drug development.
GeneCentric
This company develops gene expression-based liquid biopsy platforms and biomarkers to help pharmaceutical and diagnostic firms identify cancer treatment responders.
Trapelo Health
The company provides a decision-support platform for oncologists, labs and insurers to facilitate molecular testing and precision medicine treatment selection for cancer patients.
